What is the Arvee Laboratories PE ratio today?
Arvee Laboratories' PE ratio is 56.2 at the 30 October 2026 close (₹206.71 a share): a market capitalisation of ₹228 crore divided by consolidated net profit of ₹4.1 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹2.5 crore) it is 90.2.
What is the Arvee Laboratories debt to equity ratio?
Arvee Laboratories' debt-to-equity ratio was 0.03 on 31 March 2026: borrowings of ₹1.1 crore against total equity of ₹33.8 crore. A year earlier, on 31 March 2025, it was 0.03.
What is the Arvee Laboratories net worth?
Arvee Laboratories' net worth — shareholders' equity in its consolidated balance sheet — was ₹33.8 crore on 31 March 2026, up 8.1% from ₹31.3 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹228 crore at the 30 October 2026 close.
What is the Arvee Laboratories PB ratio (price to book value)?
Arvee Laboratories' price-to-book (PB) ratio is 6.74 at the 30 October 2026 close: a market capitalisation of ₹228 crore divided by shareholders' equity (book value) of ₹33.8 crore on 31 March 2026. That is a book value of ₹30.66 per share against a share price of ₹206.71.
What is the Arvee Laboratories ROE and ROCE?
In FY26, Arvee Laboratories' return on equity (ROE) was 7.8% and its return on capital employed (ROCE) was 5.7%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 7.1% and ROCE 7.6%.
What is the Arvee Laboratories book value per share?
Arvee Laboratories' book value per share was ₹30.66 on 31 March 2026: shareholders' equity of ₹33.8 crore divided by the 1.1 crore shares in issue, up 8.1% from ₹28.37 a year earlier. The share price at the 30 October 2026 close was ₹206.71.
What is the Arvee Laboratories market cap?
Arvee Laboratories' market capitalisation was ₹228 crore at the 30 October 2026 close: 1.1 crore shares at ₹206.71 each.
Is Arvee Laboratories debt free?
No. Arvee Laboratories had borrowings of ₹1.1 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.03. Its cash and current investments were ₹3.3 crore, so it held net cash of ₹2.2 crore.
What is the Arvee Laboratories EPS?
Arvee Laboratories' basic earnings per share (EPS) were ₹2.29 in FY26, against ₹1.95 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹3.68.
What is the Arvee Laboratories promoter holding?
Promoters held 73.50% of Arvee Laboratories on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
What is the Arvee Laboratories shareholding pattern?
On 30 September 2026, Arvee Laboratories' shares were held by promoters 73.50% and retail and other non-institutional investors 26.50%.
What is the Arvee Laboratories free cash flow?
In FY26, Arvee Laboratories generated ₹12 lakh of cash from operations and spent ₹2.8 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹3 crore. In FY25 it was −₹1.9 crore.
What are the Arvee Laboratories latest quarterly results?
Arvee Laboratories' latest results are for Q1 FY27 (April–June 2026), filed on 7 August 2026: consolidated net profit ₹1.7 crore, up 901.9% from ₹17 lakh in Q1 FY26; revenue from operations ₹17.2 crore, up 130.3% year on year.
What is the Arvee Laboratories revenue and profit in FY26?
In FY26 (April 2025–March 2026), Arvee Laboratories' consolidated net profit was ₹2.5 crore, up 17.7% from ₹2.1 crore in FY25, on revenue from operations of ₹31.5 crore (down 18.1%). Over three years, from FY23, net profit was down 38.7%.
When are the Arvee Laboratories next results?
Arvee Laboratories will announce its Q2 FY27 results (July–September 2026) on Tuesday, 3 November 2026, the date of the board meeting it has notified to the exchanges.
How does Arvee Laboratories compare with its peers?
On FY26 consolidated figures, against Spacenet Enterprises India, GVP Infotech and M TEK COPPER: Arvee Laboratories' operating margin of 6.3% is the second highest of the four (Spacenet Enterprises India 6.8%, GVP Infotech −1,415.6%, M TEK COPPER 3.8%; peer average −468.4%); its return on equity of 7.8% is the third highest of the four (Spacenet Enterprises India 9.8%, GVP Infotech −73.8%, M TEK COPPER 11.2%; peer average −17.6%).
Arvee Laboratories vs Spacenet Enterprises India: how do they compare?
In FY26, Arvee Laboratories earned net profit of ₹2.5 crore on revenue of ₹31.5 crore, against ₹16.1 crore on ₹195 crore for Spacenet Enterprises India. Arvee Laboratories' operating margin was 6.3% (Spacenet Enterprises India 6.8%) and its return on equity 7.8% (Spacenet Enterprises India 9.8%). At the 30 October 2026 close, Arvee Laboratories' market capitalisation was ₹228 crore against ₹178 crore for Spacenet Enterprises India, and its PE ratio on FY26 profit 90.2 against 11.1.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
